Behind the competition of the world’s pharmaceutical giants for the sale and export of Corona vaccine, there is a big war for big money and the multi-billion dollar global vaccine market.
Global Research wrote in an article by Professor Michel Chesudowski, founder and director of the Center for Globalization Research and Professor of Economics at the University of Ottawa, Canada: The world decided to give a hand in the form of a strategic partnership. The news of this partnership was not widely reported in the media.
Dear Audience, The content and claims made in this report have been published solely for the purpose of analyzing the approaches and views of Western think tanks, and the possible claims and inductions of these materials have never been confirmed by the East.
The dubious partnership of the two world drug giants just before the Corona crisis
In August 2019, GlaxoSmithKline confirmed in a press release the formation of a major partnership with Pfizer entitled “Consumer Health Joint Venture”:”GlaxoSmithKlein announced today that it has finalized an agreement with Pfizer to unite its consumer health businesses as a global joint venture.”
Despite the emphasis on the fact that this relationship is limited to “reputable brands in the field of consumer health”, the contract is nonetheless comprehensive. The deal covers financial issues as well as potential multibillion-dollar joint venture projects.
The agreement does not mean merging businesses, but GlaxoSmithKline’s report refers to selective mergers (implicit collusion) in marketing and distribution: “The joint venture [GlaxoSmithKlein-Pfizer] is focusing on completing the integration process [of consumer health products] of two businesses, which is expected to increase total cash costs to 9/0 billion and total non-cash costs to 3/0 billion, and save Achieve 5/0 billion in annual spending by 2022. “Up to 25 percent of the cost savings are to be reinvested in support of innovation and other growth opportunities.”
Vaccine market
Currently, five multinational companies, including GlaxoSmithKline and Pfizer, control 80% of the global vaccine market. Under the agreement between GlaxoSmithKline and Pfizer, the two companies are set to play a dominant role in coordinating the Covid-19 vaccine.
The relationship between GlaxoSmithKline and Pfizer also includes a network of partner pharmaceutical companies, research laboratories, virological institutes, military and biotechnology institutions, etc., many of which are currently involved in the Covid vaccine initiative.
Financing the Covid vaccine with the peak of government debt
The Covid vaccine production process is a multibillion-dollar project that will increase government debt by more than 150 governments. The impetus behind this initiative is not public health but money, and it has created panic: ” Completing the joint venture with Pfizer marks the beginning of the next phase of our efforts to transform GlaxoSmithKline. “This is an important moment for the group and paves the way for two large companies, one in the field of pharmacy and vaccine manufacturing and the other in the field of consumer health .” (GlaxoSmithKlein, August 1, 2019),
“Although the two companies have envisaged a ‘separation’ clause following the restructuring process, GlaxoSmithKline and Pfizer have integrated their decision-making process specifically into the vaccine market,” Global Research said. : “According to our intention to divorce in the future, the agreement also as a transparent way to GlaxoSmithKline , a global company in the field of pharmaceutical / vaccine establish an approach in the field of research and development on science-related immune system, “It focuses on the use of genetics , and advanced technologies. … Ultimately, our goal is to create two exceptional global companies in the UK with well-capitalized structures.” (GlaxoSmithKline)
The issue is the actual creation of a global monopoly of large pharmaceutical companies in the form of global networks of “partners”. Most of the so-called 125 options (“small pharmaceutical companies”) are involved in subcontracting, manufacturing, and marketing activities on behalf of large pharmaceutical companies.
Initiative of Kovacs and large pharmaceutical companies
The Kovacs initiative was launched in April 2020 to facilitate the global distribution of the corona vaccine. The initiative is organized by the Innovative Disease Preparation Coalition (CEPI), the World Vaccine and Immunization Alliance (GAVI), the Vaccine Alliance, and the World Health Organization (all of which are partly funded by the Gates Foundation).
The Gates Foundation, in turn, is a major shareholder in major vaccine pharmaceutical companies such as GlaxoSmithKline and Pfizer: ” Sanofi and GlaxoSmithKline in July of about 1.2 billion dollars of immediate America vaccination campaigns in support of large-scale production of a vaccine based on recombinant proteins help received and 100 million doses of vaccine were available to the federal government. “These companies also have vaccine supply agreements with the United Kingdom, Canada, and the Global Alliance on Vaccines and Immunizations .” (BioWord, December 2020)The GlaxoSmithKlein-Pfizer Joint Venture Alliance is used to expand control over vaccine sales and production in all major regions of the world, including China and Latin America, through networks of corporate and scientific partners. Other major players include Sanofi France with GlaxoSmithKline shares, Mdrna that are associated with Pfizer, Merck , AstraZeneca , and Jansvnand Johnson .
The launch of the Covid vaccine in November 2020
Were standard laboratory tests performed on mice? Or did Pfizer and Moderna “go straight to humans and use humans as mice”? Human experiments began in late July and early August. “It has never happened before that the testing of a new vaccine is limited to a period of three months. “It usually takes a few years.”
Why do we need the Covid-19 vaccine when the World Health Organization and the US Centers for Disease Control and Prevention have both explicitly acknowledged that Covid-19 is ” like a seasonal flu “? The unspoken answer is “big money”.
The largest vaccine manufacturing operation in the history of the world
The Covid-19 vaccine program is a benefit-oriented program. The program is backed by corrupt governments that serve the interests of large pharmaceutical companies. The US government ordered 100 million doses of the vaccine in July 2020, and the European Union is set to purchase 300 million doses. Big money for big drug companies and generous rewards for corrupt politicians at the expense of taxpayers.
The ultimate goal is to make money by vaccinating the entire population of 7.8 billion people against SARS-Covid-2 disease.
Covid vaccine in some cases contains more than one dose. If the plan goes according to plan, it will be the largest vaccine initiative in the history of the world and the largest monetization operation for large pharmaceutical companies. In addition, following the Pfizer-Modern initiative, the mRNA vaccine will affect the human genome.
ID2020 Digital Identity Vaccine Platform
There is also the Global Vaccine and Immunity Alliance project to implement a “digital passport”. The project, called the ID2020 Agenda , includes ” an electronic identity program that uses generalized vaccination as a platform for digital identity, ” according to Peter Quing .
“This program utilizes existing birth registration and vaccination operations to assign a permanent, mobile biometric digital identity to infants.” The founding partners of the ID2020 project include Microsoft , the Rockefeller Foundation , and the Global Alliance on Vaccines and Immunizations .
The timing is not without merit : The ID2020 Coalition held its “Rise for the Challenge of Good Identity” meeting in New York on September 19, 2019, just one month before the 2019 Covid Simulation Exercise 201 event at Johns Hopkins University New York: “Is it a coincidence that ID2020 coincides with the start of what the World Health Organization calls an epidemic?” “Or was it an epidemic for ID2020 to run multiple malicious programs?”
Global Research concludes that the ID2020 program is part of a “global governance” project that, if implemented, will achieve what some analysts call a global police situation and collect the personal information of billions of people around the world through vaccination.
